John Rogers's CRL Position Overview
John Rogers (via Ariel Investments, LLC) currently holds 0 shares of Charles River Laboratories International, Inc. (CRL) worth $0, representing 0.00% of the portfolio. First purchased in , this recently established position has been held for 0 quarters.
Based on recent 13F filings, John Rogers has initiated a new position in CRL, representing a fresh investment thesis on this company. Largest addition occurred in Q1 2017, adding 483,564 shares. Largest reduction occurred in Q1 2014, reducing 619,955 shares.
Analysis based on 13F filings available since 2013 Q2
John Rogers's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by John Rogers
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| No data available | ||||
John Rogers's Charles River Laboratories International Investment FAQs
According to the latest 13F filing for Q3 2025, John Rogers's firm, Ariel Investments, LLC, owns 1,490,098 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $233.14 M.
As of the Q3 2025 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 2.49% of John Rogers's publicly disclosed stock portfolio, making it one of their key holdings.
John Rogers's peak holding in Charles River Laboratories International, Inc. (CRL) was 2,749,905 shares, as reported at the end of Q3 2013.